Integrated Filing — IndAS

General information about company
Scrip Code	532899
NSE Symbol	KSCL
MSEI Symbol	NOTLISTED
ISIN	INE455I01029
Name of company	Kaveri Seed Company Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	19-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	03-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Produce and selling of sowing seeds
Start date and time of board meeting	19-May-2025   12:00:00
End date and time of board meeting	19-May-2025   14:45:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Not applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	902520000	12049704000
	Other income	126981000	463005000
	Total income	1029501000	12512709000
2	Expenses
(a)	Cost of materials consumed	2408614000	9749624000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-2037003000	-3620023000
(d)	Employee benefit expense	365028000	1398508000
(e)	Finance costs	860000	1900000
(f)	Depreciation, depletion and amortisation expense	156830000	398310000
(f)	Other Expenses
1	Other Expenses	331249000	1612200000
	Total other expenses	331249000	1612200000
	Total expenses	1225578000	9540519000
3	Total profit before exceptional items and tax	-196077000	2972190000
4	Exceptional items	0	0
5	Total profit before tax	-196077000	2972190000
6	Tax expense
7	Current tax	3766000	104832000
8	Deferred tax	28729000	44546000
9	Total tax expenses	32495000	149378000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-228572000	2822812000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-228572000	2822812000
17	Other comprehensive income net of taxes	-11110000	-12034000
18	Total Comprehensive Income for the period	-239682000	2810778000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	-229438000	2813269000
	Total profit or loss, attributable to non-controlling interests	866000	866000
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	-240480000	2801348000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	798000	9430000
21	Details of equity share capital
	Paid-up equity share capital	102878000	102878000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		14888709000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-4.53	55.1
	Diluted earnings (loss) per share from continuing operations	-4.53	55.1
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-4.53	55.1
	Diluted earnings (loss) per share from continuing and discontinued operations	-4.53	55.1
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company in their respective meetings held on May 19, 2025. The above quarterly financial results are available on the company's website: www.kaveriseeds.in and also in NSE and BSE websites. n n2. The company and its subsidiaries are engaged in the business of sale of Seeds and Micronutrients and there are no other reportable segments under Ind AS 108 Operating Segments. n n3. The figures for quarter ended March 31, 2025 and March 31, 2024 are the balancing figures between audited figures in respect of the full financial year up to March 31, 2025 and March 31, 2024 respectively and unaudited published year to date figures up to December 31, 2024 and December 31, 2023 respectively. n n4. In respect of one of the Subsidiary Company, the accumulated losses incurred of Rs. 530.91 Lakhs on March 31, 2025 (31.03.2024: Rs. 533.36 Lakhs) have resulted in the negative net worth of Rs. 488.98 lakhs (31.03.2024: Rs. 491.43 Lakhs). The Subsidiary’s current liabilities, as on 31.03.2025, exceed its current assets by Rs. 523.06 Lakhs (31.03.2024: Rs. 525.52 Lakhs) and turnover during the year ended March 31, 2025 is Rs. NIL (FY 2023-24: Rs. NIL). Due to the lack of working capital required the operations of the Subsidiary Company have been substantially curtailed and its ability to continue as a going concern is solely dependent upon the infusion of funds for its operations. n n5. During the current period the Company has received a demand notice for Rs.6958.75 lakhs from the Income Tax Authorities for the Assessment Year 2023-24 mainly by disallowing the exemption of agriculture income claimed by the company. The company strongly believes it is entitled to the exemption of agriculture income from tax and the company has filed appeal before the respective authority by taking the appropriate counsel in this regard. n

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	4158055000
	Capital work-in-progress	891305000
	Investment property
	Goodwill	2670000
	Other intangible assets	8399000
	Intangible assets under development	4027000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	41630000
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets
	Total non-current financial assets	41630000
	Deferred tax assets (net)	46981000
	Other non-current assets	903487000
	Total non-current assets	6056554000
2	Current assets
	Inventories	10286305000
	Current financial asset
	Current investments	6093079000
	Trade receivables, current	924377000
	Cash and cash equivalents	204063000
	Bank balance other than cash and cash equivalents	1221000
	Loans, current	0
	Other current financial assets
	Total current financial assets	7222740000
	Current tax assets (net)
	Other current assets	2966966000
	Total current assets	20476011000
3	Non-current assets classified as held for sale	1640000
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	26534205000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	102878000
	Other equity	14888709000
	Total equity attributable to owners of parent	14991587000
	Non controlling interest	42958000
	Total equity	15034545000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities	74685000
	Total non-current financial liabilities	74685000
	Provisions, non-current	210261000
	Deferred tax liabilities (net)	181177000
	Deferred government grants, Non-current
	Other non-current liabilities	124607000
	Total non-current liabilities	590730000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	169595000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	4639611000
	Total Trade payable	4809206000
	Other current financial liabilities	28359000
	Total current financial liabilities	4837565000
	Other current liabilities	6050629000
	Provisions, current	18510000
	Current tax liabilities (Net)	2226000
	Deferred government grants, Current	0
	Total current liabilities	10908930000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	11499660000
	Total equity and liabilites	26534205000
	Disclosure of notes on assets and liabilities	Textual Information(1)

Text Block

Textual Information(1)

1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company in their respective meetings held on May 19, 2025. The above quarterly financial results are available on the company's website: www.kaveriseeds.in and also in NSE and BSE websites. n n2. The company and its subsidiaries are engaged in the business of sale of Seeds and Micronutrients and there are no other reportable segments under Ind AS 108 Operating Segments. n n3. The figures for quarter ended March 31, 2025 and March 31, 2024 are the balancing figures between audited figures in respect of the full financial year up to March 31, 2025 and March 31, 2024 respectively and unaudited published year to date figures up to December 31, 2024 and December 31, 2023 respectively. n n4. In respect of one of the Subsidiary Company, the accumulated losses incurred of Rs. 530.91 Lakhs on March 31, 2025 (31.03.2024: Rs. 533.36 Lakhs) have resulted in the negative net worth of Rs. 488.98 lakhs (31.03.2024: Rs. 491.43 Lakhs). The Subsidiary’s current liabilities, as on 31.03.2025, exceed its current assets by Rs. 523.06 Lakhs (31.03.2024: Rs. 525.52 Lakhs) and turnover during the year ended March 31, 2025 is Rs. NIL (FY 2023-24: Rs. NIL). Due to the lack of working capital required the operations of the Subsidiary Company have been substantially curtailed and its ability to continue as a going concern is solely dependent upon the infusion of funds for its operations. n n5. During the current period the Company has received a demand notice for Rs.6958.75 lakhs from the Income Tax Authorities for the Assessment Year 2023-24 mainly by disallowing the exemption of agriculture income claimed by the company. The company strongly believes it is entitled to the exemption of agriculture income from tax and the company has filed appeal before the respective authority by taking the appropriate counsel in this regard. n

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Unaudited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified subsequently to profit or loss	-13037000	-13817000
	Total Amount of items that will not be reclassified to profit and loss	-13037000	-13817000
2	Income tax relating to items that will not be reclassified to profit or loss	-707000	-721000
3	Amount of items that will be reclassified to profit and loss
1	Items that will be reclassified subsequently to profit or loss	1508000	1258000
	Total Amount of items that will be reclassified to profit and loss	1508000	1258000
4	Income tax relating to items that will be reclassified to profit or loss	288000	196000
5	Total Other comprehensive income	-11110000	-12034000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Unaudited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			2972190000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			1900000
	Adjustments for decrease (increase) in inventories			-3800765000
	Adjustments for decrease (increase) in trade receivables, current			194478000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-433121000
	Adjustments for decrease (increase) in other non-current assets			-16787000
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			2051000
	Adjustments for increase (decrease) in trade payables, current			2339521000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			943688000
	Adjustments for increase (decrease) in other non-current liabilities			-8558000
	Adjustments for depreciation and amortisation expense			398311000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			3141000
	Adjustments for provisions, non-current			32085000
	Adjustments for other financial liabilities, current			-760000
	Adjustments for other financial liabilities, non-current			29423000
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			0
	Adjustments for interest income			0
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-206760000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			-224652000
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-746805000
	Net cash flows from (used in) operations			2225385000
	Dividends received			-290000
	Interest paid			0
	Interest received			-2498000
	Income taxes paid (refund)			251448000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			1971149000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			2199000
	Purchase of property, plant and equipment			883547000
	Proceeds from sales of investment property			3698468000
	Purchase of investment property			4642235000
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			5041000
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			290000
	Interest received			2522000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	-1827344000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			80297000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			1301000
	Payments of lease liabilities			0
	Dividends paid			255697000
	Interest paid			0
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-1901000
	Net cash flows from (used in) financing activities			-178602000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-34797000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-34797000
	Cash and cash equivalents cash flow statement at beginning of period			238860000
	Cash and cash equivalents cash flow statement at end of period			204063000